Logo image of CYAN

CYANOTECH CORP (CYAN) Stock Fundamental Analysis

NASDAQ:CYAN - Nasdaq - US2324373016 - Common Stock - Currency: USD

0.44  -0.01 (-2.96%)

After market: 0.4499 +0.01 (+2.25%)

Fundamental Rating

1

CYAN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. CYAN has a bad profitability rating. Also its financial health evaluation is rather negative. CYAN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CYAN has reported negative net income.
CYAN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CYAN reported negative net income in multiple years.
In multiple years CYAN reported negative operating cash flow during the last 5 years.
CYAN Yearly Net Income VS EBIT VS OCF VS FCFCYAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.95%, CYAN is doing worse than 67.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of -33.40%, CYAN is in line with its industry, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
ROA -16.95%
ROE -33.4%
ROIC N/A
ROA(3y)-0.63%
ROA(5y)-2.56%
ROE(3y)-1.54%
ROE(5y)-5.26%
ROIC(3y)N/A
ROIC(5y)N/A
CYAN Yearly ROA, ROE, ROICCYAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

CYAN has a Gross Margin of 29.61%. This is in the lower half of the industry: CYAN underperforms 72.97% of its industry peers.
In the last couple of years the Gross Margin of CYAN has declined.
CYAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.69%
GM growth 5Y-4.38%
CYAN Yearly Profit, Operating, Gross MarginsCYAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

More info and screens

1

2. Health

2.1 Basic Checks

CYAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CYAN has more shares outstanding
Compared to 5 years ago, CYAN has more shares outstanding
Compared to 1 year ago, CYAN has a worse debt to assets ratio.
CYAN Yearly Shares OutstandingCYAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
CYAN Yearly Total Debt VS Total AssetsCYAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

CYAN has an Altman-Z score of -0.42. This is a bad value and indicates that CYAN is not financially healthy and even has some risk of bankruptcy.
CYAN has a worse Altman-Z score (-0.42) than 78.38% of its industry peers.
CYAN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
CYAN has a Debt to Equity ratio of 0.26. This is comparable to the rest of the industry: CYAN outperforms 56.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -0.42
ROIC/WACCN/A
WACC8.45%
CYAN Yearly LT Debt VS Equity VS FCFCYAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.44 indicates that CYAN should not have too much problems paying its short term obligations.
CYAN has a Current ratio (1.44) which is in line with its industry peers.
CYAN has a Quick Ratio of 1.44. This is a bad value and indicates that CYAN is not financially healthy enough and could expect problems in meeting its short term obligations.
CYAN has a Quick ratio of 0.37. This is amonst the worse of the industry: CYAN underperforms 89.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.37
CYAN Yearly Current Assets VS Current LiabilitesCYAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CYAN have decreased strongly by -153.67% in the last year.
The Revenue for CYAN has decreased by -13.23% in the past year. This is quite bad
Measured over the past years, CYAN shows a decrease in Revenue. The Revenue has been decreasing by -7.44% on average per year.
EPS 1Y (TTM)-153.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.63%
Revenue 1Y (TTM)-13.23%
Revenue growth 3Y-10.1%
Revenue growth 5Y-7.44%
Sales Q2Q%-5.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYAN Yearly Revenue VS EstimatesCYAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CYAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYAN Price Earnings VS Forward Price EarningsCYAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYAN Per share dataCYAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CYAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYANOTECH CORP

NASDAQ:CYAN (2/16/2024, 8:00:01 PM)

After market: 0.4499 +0.01 (+2.25%)

0.44

-0.01 (-2.96%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-08 2024-02-08/amc
Earnings (Next)06-25 2024-06-25/bmo
Inst Owners2.58%
Inst Owner Change-45.15%
Ins Owners44.58%
Ins Owner Change0.37%
Market Cap3.03M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)-0.74
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS3.26
BVpS2.01
TBVpS2.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.95%
ROE -33.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.61%
FCFM N/A
ROA(3y)-0.63%
ROA(5y)-2.56%
ROE(3y)-1.54%
ROE(5y)-5.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.69%
GM growth 5Y-4.38%
F-Score2
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.94%
Cap/Sales 1.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.37
Altman-Z -0.42
F-Score2
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)62.42%
Cap/Depr(5y)45.28%
Cap/Sales(3y)3.5%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.23%
Revenue growth 3Y-10.1%
Revenue growth 5Y-7.44%
Sales Q2Q%-5.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-200.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-129.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-106.45%
OCF growth 3YN/A
OCF growth 5YN/A